leadf
logo-loader
viewBiogen Inc

Biogen to produce first therapy for Alzheimer’s if FDA approves next year

Aducanumab aims at reducing the clinical decline of the disease rather than the underlying cause

Biogen Inc - Biogen to produce first therapy for Alzheimer’s if FDA approves next year

Biogen Inc’s (NASDAQ:BIIB) potential treatment for Alzheimer’s would become the first therapy of its kind if approved by the US Food and Drug Administration (FDA).

It aims at reducing the clinical decline of the disease, which accounts for 60-80% of dementia cases, rather than the underlying cause.

It would stop the deterioration of cognitive abilities so patients can perform daily activities, including conducting personal finances, performing household chores and independently travelling out of the home. 

The FDA, which granted priority review to aducanumab, is expected to take a decision by next March.

The pharma company stopped the final phase of clinical trials last year after early data showed it would not be beneficial for patients in the early stages of the disease.

But Biogen applied to the FDA after retrieving a wider pool of data, while it is also planning a new study involving the same participants of the previous trial.

“We believe that aducanumab marks the beginning of a new era of potential treatments for Alzheimer’s disease that will inspire even more discovery and innovation to bring hope to those affected by this devastating disease,” said chief executive Michel Vounatsos.

Shares added 1% to US$309.34 in premarket trading.

Quick facts: Biogen Inc

Price: 274.48 USD

NASDAQ:BIIB
Market: NASDAQ
Market Cap: $43.45 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Luminex Resources CEO says stay tuned for drill results out of its Condor...

Luminex Resources Corp. (TSXV: LR) (OTCQX: LUMIF) CEO Marshall Koval tells Proactive the Vancouver-based mining company is making progress on its Condor Gold-Copper Project in Zamora-Chinchipe Province, southeast Ecuador. Koval says the group has advanced metallurgy at the site, continuing to...

2 days, 6 hours ago

2 min read